Related Experiment Video

Updated: Jun 19, 2025

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis
11:44

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis

Published on: March 30, 2019

7.6K

Role of AMIGO2 in cancer progression: Novel insights (Review)

Zhen Tian1, Dongsheng Zhou1, Rui Jiang1

  • 1Department of Oncology, Huishan Third People's Hospital of Wuxi, Wuxi, Jiangsu 214183, P.R. China.

Oncology Letters
|July 25, 2024
PubMed

Insights

Adhesion molecule with IgG-like domain 2 (AMIGO2) is an oncogene promoting cancer progression by inhibiting apoptosis and enhancing metastasis. Targeting AMIGO2 offers a promising strategy for future cancer therapies.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Adhesion molecule with IgG-like domain 2 (AMIGO2) is a scaffold protein involved in neuronal apoptosis.
  • AMIGO2 is expressed in various cancers, including gastric, colorectal, ovarian, prostate, and melanoma.
  • AMIGO2 functions as an oncogene in tumor development and progression.

Purpose of the Study:

  • To review recent advancements in understanding AMIGO2's role in cancer.
  • To emphasize the molecular mechanisms underlying AMIGO2's oncogenic functions.
  • To identify novel therapeutic strategies targeting AMIGO2 for cancer treatment.

Main Methods:

  • Literature review of studies on AMIGO2 in cancer.
  • Analysis of molecular mechanisms of AMIGO2 in tumor occurrence and development.
  • Synthesis of information on AMIGO2's role in apoptosis inhibition, cell proliferation, migration, adhesion, metastasis, and drug resistance.

Main Results:

  • AMIGO2 promotes tumor occurrence and development.
  • AMIGO2 inhibits apoptosis, accelerates cell proliferation, migration, and adhesion.
  • AMIGO2 enhances tumor metastasis and drug resistance.

Conclusions:

  • AMIGO2 is a significant oncogene in various cancers.
  • Understanding AMIGO2's molecular mechanisms is crucial for developing targeted therapies.
  • Targeting AMIGO2 presents a promising therapeutic strategy for future cancer treatment.
Keywords:
adhesion molecule with IgG-like domain 2colorectal carcinomagastric cancerovarian cancerprostate cancer

More Related Videos

Characterization of Functionally Associated miRNAs in Glioblastoma and their Engineering into Artificial Clusters for Gene Therapy09:40

Characterization of Functionally Associated miRNAs in Glioblastoma and their Engineering into Artificial Clusters for Gene Therapy

Published on: October 4, 2019

5.6K
Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies07:47

Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies

Published on: September 15, 2023

1.4K

Related Concept Videos

The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.5K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.8K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.4K
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K